FDANonrulemakingFDA-2018-D-0338

Who commented on this docket

Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act

7 organizations filed 10 public comments on Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act, at the Food and Drug Administration. The comment window closed 3039d ago.

Organizations
7
Comments
10
RIN
Comment window
closed 3039d ago

Commenters (7)

  • Healthcare Distribution Alliancetrade assoc.
    2 filings · confidence 85%
  • Pharmaceutical Distribution Security Alliancetrade assoc.
    2 filings · confidence 85%
  • Healthcare Supply Chain Associationtrade assoc.
    1 filing · confidence 85%
  • McKesson Corporationunverified attribution
    1 filing · confidence 70%
  • National Association of Boards of Pharmacytrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.